Published in Physiol Rev on October 01, 1997
Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol (2008) 3.45
Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol (2010) 3.12
The role of saliva in tick feeding. Front Biosci (Landmark Ed) (2009) 2.73
Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy (2005) 2.32
The tyrosine kinase network regulating mast cell activation. Immunol Rev (2009) 2.29
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature (2014) 2.26
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest (2002) 2.22
Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A (2005) 2.19
Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest (2006) 2.12
Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res (2013) 2.06
So depression is an inflammatory disease, but where does the inflammation come from? BMC Med (2013) 2.02
Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis. Dig Dis Sci (2011) 1.90
Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells. Mol Biol Cell (2004) 1.85
Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest (2003) 1.85
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci U S A (2007) 1.84
Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol (2010) 1.78
Development, migration, and survival of mast cells. Immunol Res (2006) 1.78
Mast cell degranulation activates a pain pathway underlying migraine headache. Pain (2007) 1.74
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Mast cells in atopic dermatitis. Curr Opin Immunol (2009) 1.63
Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing. J Exp Med (2001) 1.61
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology (2002) 1.56
Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci (2007) 1.50
Regulation of mast cell responses in health and disease. Crit Rev Immunol (2011) 1.50
Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am J Physiol Gastrointest Liver Physiol (2009) 1.49
Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A (2008) 1.48
T-cell-dependent control of acute Giardia lamblia infections in mice. Infect Immun (2000) 1.48
Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells. Blood (2013) 1.47
Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells. Eur J Immunol (2013) 1.47
Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol (2013) 1.47
Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma : Possible relevance to human fibrotic disorders. Proc Natl Acad Sci U S A (2002) 1.44
Mast cells and angiogenesis in oral malignant and premalignant lesions. Open Dent J (2008) 1.42
Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest (2000) 1.40
Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res (2003) 1.38
Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res (2007) 1.36
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation. Immunol Lett (2007) 1.33
Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther (2007) 1.32
Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol (1999) 1.31
MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J (2000) 1.30
Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. BMC Immunol (2002) 1.28
The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol (2008) 1.27
Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J Clin Invest (2011) 1.27
Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats. J Mol Cell Cardiol (2008) 1.27
Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med (2007) 1.26
A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med (2004) 1.25
Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br J Pharmacol (2008) 1.25
Neural acupuncture unit: a new concept for interpreting effects and mechanisms of acupuncture. Evid Based Complement Alternat Med (2012) 1.25
Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood. Curr Protoc Immunol (2010) 1.23
Gross morphological features of the organ surface primo-vascular system revealed by hemacolor staining. Evid Based Complement Alternat Med (2013) 1.23
Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I {alpha}. J Exp Med (2005) 1.22
Mast cells in inflammatory arthritis. Arthritis Res Ther (2004) 1.21
Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med (2001) 1.20
Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol (2002) 1.19
Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. J Immunol (2008) 1.16
Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol (2002) 1.15
IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A (1999) 1.15
Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release. J Biol Chem (2010) 1.14
Membrane-anchored serine proteases in health and disease. Prog Mol Biol Transl Sci (2011) 1.13
Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells. Proc Natl Acad Sci U S A (2001) 1.12
Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release. Cell Signal (2008) 1.12
TLR signaling in mast cells: common and unique features. Front Immunol (2012) 1.12
Airway remodelling in asthma: from benchside to clinical practice. Can Respir J (2010) 1.11
RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci U S A (2006) 1.10
SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration. Mol Cell Biol (2004) 1.10
A catalytic role of heparin within the extracellular matrix. J Biol Chem (2008) 1.08
Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation. J Pharmacol Exp Ther (2007) 1.08
Mast cell function: a new vision of an old cell. J Histochem Cytochem (2014) 1.08
Serine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway. Pain (2010) 1.07
Mast cells are necessary for the hypothermic response to LPS-induced sepsis. Am J Physiol Regul Integr Comp Physiol (2008) 1.07
Measuring mast cell mediator release. Curr Protoc Immunol (2010) 1.07
Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells. Mol Cell Biol (2002) 1.06
Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev Biol (2009) 1.04
Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev (2007) 1.03
Stem cell factor programs the mast cell activation phenotype. J Immunol (2012) 1.03
Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem J (2007) 1.03
Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. Int J Exp Pathol (2009) 1.03
IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. J Exp Med (2003) 1.03
The Role of TRP Proteins in Mast Cells. Front Immunol (2012) 1.02
Tracheal telocytes. J Cell Mol Med (2012) 1.02
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts. J Pathol (2005) 1.01
C-Kit receptor (CD117) in the porcine urinary tract. Pediatr Surg Int (2008) 1.00
Inflammation and immunity in radiation damage to the gut mucosa. Biomed Res Int (2013) 1.00
Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells. J Cell Sci (2010) 0.99
Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors. BMC Immunol (2010) 0.99
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. Blood (2011) 0.99
Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med (2002) 0.98
Mast cell progenitor trafficking and maturation. Adv Exp Med Biol (2011) 0.98
Ca2+ waves initiate antigen-stimulated Ca2+ responses in mast cells. J Immunol (2009) 0.98
Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc Natl Acad Sci U S A (2007) 0.98
Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J Immunol (2010) 0.97
Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics (2006) 0.97
Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. Am J Respir Cell Mol Biol (2008) 0.96
Blood pressure regulation X: what happens when the muscle pump is lost? Post-exercise hypotension and syncope. Eur J Appl Physiol (2013) 0.96
Influence of mast cells in drug-induced gingival overgrowth. Mediators Inflamm (2013) 0.96
Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Lab Invest (2012) 0.96
Swiprosin-1 Regulates Cytokine Expression of Human Mast Cell Line HMC-1 through Actin Remodeling. Immune Netw (2009) 0.96
Low doses of low molecular weight heparin in vivo inhibits the elicitation of contact hypersensitivity. Acta Derm Venereol (1994) 1.39
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol (1990) 1.22
Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. J Immunol (1994) 1.21
Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J Immunol (2001) 1.19
Synaptotagmin II negatively regulates Ca2+-triggered exocytosis of lysosomes in mast cells. J Exp Med (1999) 1.13
Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. J Clin Invest (1989) 1.03
Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells. J Exp Med (1985) 1.01
Undiminished immunologic tolerance to contact sensitivity in mast cell-deficient W/Wv and Sl/Sld mice. J Immunol (1985) 0.99
Extracellular matrix induces tumour necrosis factor-alpha secretion by an interaction between resting rat CD4+ T cells and macrophages. Immunology (1993) 0.99
Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest (1997) 0.98
Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol (1998) 0.98
Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy (2005) 0.96
Lymphocyte subpopulations in the skin of patients with chronic urticaria. J Allergy Clin Immunol (1983) 0.96
Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol (1996) 0.94
Hexosaminidase A deficient adults: presence of alpha chain precursor in cultured skin fibroblasts. Biochem Biophys Res Commun (1984) 0.93
Rheumatoid neutrophilic dermatitis: an initial dermatological manifestation of seronegative rheumatoid arthritis. J Eur Acad Dermatol Venereol (2002) 0.92
Synaptotagmin regulates mast cell functions. Immunol Rev (2001) 0.87
Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clin Exp Immunol (1997) 0.86
Diminished chemokine and cytokine-induced adhesion of CD4+ T cells to extracellular matrix ligands in patients with end-stage renal failure. Isr Med Assoc J (2000) 0.85
Both adhesion to immobilized vitronectin and FcepsilonRI cross-linking cause enhanced focal adhesion kinase phosphorylation in murine mast cells. Immunology (1999) 0.85
Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia. Eur J Neurol (2008) 0.85
The effect of food and exercise on the skin response to compound 48/80 in patients with food-associated exercise-induced urticaria-angioedema. J Allergy Clin Immunol (1988) 0.85
Inhibition of delayed hypersensitivity reactions in mice by colchicine. I. Mechanism of inhibition of contact sensitivity in vivo. Cell Immunol (1989) 0.84
Light chain myeloma presenting as severe obstructive jaundice due to hepatic amyloidosis. Eur J Haematol (1999) 0.84
125I-fibrin deposition in contact sensitivity reactions in the mouse. Sensitivity of the assay for quantitating reactions after active or passive sensitization. J Immunol (1986) 0.84
Diminished adhesion of CD4+ T cells from dialysis patients to extracellular matrix and its components fibronectin and laminin. Nephrol Dial Transplant (1997) 0.83
Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am J Physiol (1997) 0.83
Possible role of diet in delayed pressure urticaria--preliminary report. J Allergy Clin Immunol (1986) 0.83
IgE antithyroid microsomal antibodies in a patient with chronic urticaria. J Allergy Clin Immunol (1999) 0.82
Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp. Clin Exp Immunol (1994) 0.82
Bilateral central retinal vein occlusion in a patient with occult colon cancer. Arch Ophthalmol (2001) 0.81
Adult-onset GM2 gangliosidosis diagnosed in a fetus. Prenat Diagn (1986) 0.80
Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro. Clin Exp Allergy (2004) 0.80
Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication. Ann Allergy (1984) 0.80
Osteoporosis as the sole presentation of bone marrow mastocytosis. J Bone Miner Res (1990) 0.80
Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes. Cell Immunol (1990) 0.79
Secretion of stem cell factor by alveolar fibroblasts in interstitial lung diseases. Immunol Lett (1999) 0.79
Pancreatitis in systemic lupus erythematosus--a case report and review of the literature. Postgrad Med J (1980) 0.78
Hypereosinophilic syndrome presenting as acute myocardial infarction. Allergy (2000) 0.78
Lupus-like syndrome with submassive hepatic necrosis associated with hepatitis A. J Gastroenterol Hepatol (2001) 0.78
Increased cytosolic free calcium in lymphocytes of Alzheimer patients. J Neuroimmunol (1991) 0.78
Ca2+-dependent exocytosis in mast cells is stimulated by the Ca2+ sensor, synaptotagmin I. J Immunol (1998) 0.78
Depletion of cellular beta-hexosaminidase by imipramine is prevented by dexamethasone; implications for treating psychotic hexosaminidase-A deficient patients. Biochem Biophys Res Commun (1987) 0.78
Familial Mediterranean fever and Celiac sprue--are they related? Clin Exp Rheumatol (2004) 0.78
Heat-stressed CD4+ T lymphocytes: differential modulations of adhesiveness to extracellular matrix glycoproteins, proliferative responses and tumour necrosis factor-alpha secretion. Immunology (1993) 0.77
The Cardiac Insufficiency Bisoprolol Study II. Lancet (1999) 0.77
Inhibition of T cell adhesion to extracellular matrix glycoproteins by histamine: a role for mast cell degranulation products. J Leukoc Biol (1994) 0.77
Characterization of the interference of T cell activation by reserpine. Cell Immunol (1989) 0.77
1,25-Dihydroxyvitamin D3 enhances degranulation of mast cells. Mol Cell Endocrinol (1998) 0.77
Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis. Br J Dermatol (2003) 0.77
Morphological evidence for chronic mast cell activation after prolonged exposure with supernatants from chronic graft-versus-host splenocytes. Immunol Lett (1991) 0.77
Sirolimus-associated diffuse alveolar hemorrhage in a renal transplant recipient on long-term anticoagulation. Clin Nephrol (2007) 0.77
Depressed IL-1 production by chronic GVHD dermal fibroblasts. Eur Cytokine Netw (1991) 0.76
Enkephalin and alpha-adrenergic receptors: evidence for both common and differentiable regulatory pathways and down-regulation of the enkephalin receptor. Life Sci (1983) 0.76
Mast cell adhesion to extracellular matrix: local effects of acute phase reactants. Int Arch Allergy Immunol (1997) 0.76
Effect of coculture of rodent mast cells with murine chronic graft-versus-host disease (cGVHD)-derived fibroblasts. J Allergy Clin Immunol (1992) 0.76
Motivational factors in abortion patients. Am J Psychiatry (1973) 0.76
Immunological features of preeclampsia: increased frequency of antilymphocyte antibodies, but not of immune complexes. Isr J Med Sci (1981) 0.76
Testing for food allergy--who, when and how. Isr J Med Sci (1994) 0.75
Deposits of immunoglobulins and C3 in the walls of human renal arteries. Clin Exp Immunol (1981) 0.75
Lactic acidosis and AIDS. Ann Intern Med (1993) 0.75
Desensitization of experimental contact sensitivity. J Allergy Clin Immunol (1986) 0.75
Acute anuric bilateral ureteral obstruction in malignant lymphoma. Am J Med Sci (1984) 0.75
Case report: Hepatic involvement in antiphospholipid syndrome. J Gastroenterol Hepatol (1999) 0.75
Cutaneous responses to histamine, compound 48/80 and codeine in patients with hyperthyroidism. Ann Allergy (1990) 0.75
Desensitization of contract allergy to 2,4-dinitro-1-fluorobenzene in mice. II. Characteristics of "immediate" desensitization. Cell Immunol (1984) 0.75
Intramural hematoma of the aorta: delayed pericardial tamponade. Thorac Cardiovasc Surg (2009) 0.75
Prolonged generalized pruritus associated with selective elevation of IgA as the presenting symptoms of sarcoidosis. Ann Allergy Asthma Immunol (1995) 0.75
Hemodialysis-induced rash: a unique case of cholinergic urticaria. J Allergy Clin Immunol (1995) 0.75
Anaphylaxis to cisplatin: diagnosis and value of pretreatment in prevention of recurrent allergic reactions. Ann Allergy (1994) 0.75
[Anaphylactoid reactions to radiocontrast media]. Harefuah (1995) 0.75
Down regulation of enkephalin (delta) receptors. Demonstration in membrane-bound and solubilized receptors. Biochim Biophys Acta (1982) 0.75
Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients. Ann Allergy Asthma Immunol (1995) 0.75
Cutaneous responses to histamine, compound 48/80, and codeine in patients with chronic renal failure. Ann Allergy (1991) 0.75
Inhibition by uraemic sera of CD4+ T-cell adhesion to extracellular matrix components. Nephrol Dial Transplant (1995) 0.75
Nedocromil sodium inhibits T-cell function in vitro and in vivo. J Allergy Clin Immunol (1993) 0.75
Desensitization of contact allergy to DNFB in mice. III. Characteristics of immediate desensitization induced by haptenated spleen cells. Cell Immunol (1986) 0.75
Analysis of mast cell function in biological responses not involving IgE. Int Arch Allergy Appl Immunol (1987) 0.75
Receptors and post-receptors alterations induced by opiates and solubilization of opiate receptors. Adv Biochem Psychopharmacol (1982) 0.75
Cutaneous polyarteritis nodosa associated with rapidly progressive arthritis. Arthritis Rheum (1984) 0.75
Is graft-versus-host disease a reliable model for scleroderma? Ric Clin Lab (1987) 0.75
The effect of IgE-mediated mast cell degranulation on the expression of experimental contact sensitivity in the mouse. Cell Immunol (1987) 0.75
Late cutaneous reactions in patients with delayed pressure urticaria. J Allergy Clin Immunol (1984) 0.75
Deliberate bee sting challenge of patients receiving maintenance venom immunotherapy at 3-month intervals. J Allergy Clin Immunol (1994) 0.75
Sex-linked hypogammaglobulinemia and amyloidosis. Arch Pathol Lab Med (1982) 0.75
Cytokine production and matrix metalloproteinase (MMP)-9 release by human mast cells following cell-to-cell contact with activated T cells. Isr Med Assoc J (2000) 0.75
Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children. Ann Allergy Asthma Immunol (1997) 0.75
Enkephalins and opiate antagonists control calmodulin distribution in neuroblastoma-glioma cells. J Neurochem (1983) 0.75
Appearance of macrophage migration inhibition factor in patients with systemic reactions to bee venom. Int Arch Allergy Appl Immunol (1991) 0.75
The effect of histamine receptor antagonists on specific and nonspecific suppression of experimental contact sensitivity. J Allergy Clin Immunol (1985) 0.75
Prostaglandin E2 production by chronic graft-versus-host disease dermal fibroblasts. Immunol Lett (1995) 0.75
Oncostatin m in bronchoalveolar lavage correlates with the severity of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.75